Global Hospital-acquired infections (HAIs) Control Market Growth (Status and Outlook) 2024-2030

December 2024 | 95 pages | ID: G29AD6A78652EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Hospital-acquired infections (HAIs) Control market size was valued at US$ 5578.1 million in 2023. With growing demand in downstream market, the Hospital-acquired infections (HAIs) Control is forecast to a readjusted size of US$ 6859.5 million by 2030 with a CAGR of 3.0% during review period.

The research report highlights the growth potential of the global Hospital-acquired infections (HAIs) Control market. Hospital-acquired infections (HAIs) Control are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hospital-acquired infections (HAIs) Control. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hospital-acquired infections (HAIs) Control market.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Key Features:

The report on Hospital-acquired infections (HAIs) Control market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Hospital-acquired infections (HAIs) Control market. It may include historical data, market segmentation by Type (e.g., Diagnostic techniques, Dleaning and sterilization), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hospital-acquired infections (HAIs) Control market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Hospital-acquired infections (HAIs) Control market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Hospital-acquired infections (HAIs) Control industry. This include advancements in Hospital-acquired infections (HAIs) Control technology, Hospital-acquired infections (HAIs) Control new entrants, Hospital-acquired infections (HAIs) Control new investment, and other innovations that are shaping the future of Hospital-acquired infections (HAIs) Control.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hospital-acquired infections (HAIs) Control market. It includes factors influencing customer ' purchasing decisions, preferences for Hospital-acquired infections (HAIs) Control product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hospital-acquired infections (HAIs) Control market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hospital-acquired infections (HAIs) Control market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hospital-acquired infections (HAIs) Control market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hospital-acquired infections (HAIs) Control industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hospital-acquired infections (HAIs) Control market.

Market Segmentation:

Hospital-acquired infections (HAIs) Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Diagnostic techniques
  • Dleaning and sterilization
  • Treatment
Segmentation by application
  • General Hospital
  • Infectious Disease Hospital
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • STERIS Corporation
  • Advanced Sterilization Products Division
  • Hoffmann-La Roche
  • Pfizer
  • Becton Dickinson
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hospital-acquired infections (HAIs) Control Market Size 2019-2030
  2.1.2 Hospital-acquired infections (HAIs) Control Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hospital-acquired infections (HAIs) Control Segment by Type
  2.2.1 Diagnostic techniques
  2.2.2 Dleaning and sterilization
  2.2.3 Treatment
2.3 Hospital-acquired infections (HAIs) Control Market Size by Type
  2.3.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
2.4 Hospital-acquired infections (HAIs) Control Segment by Application
  2.4.1 General Hospital
  2.4.2 Infectious Disease Hospital
2.5 Hospital-acquired infections (HAIs) Control Market Size by Application
  2.5.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)

3 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SIZE BY PLAYER

3.1 Hospital-acquired infections (HAIs) Control Market Size Market Share by Players
  3.1.1 Global Hospital-acquired infections (HAIs) Control Revenue by Players (2019-2024)
  3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL BY REGIONS

4.1 Hospital-acquired infections (HAIs) Control Market Size by Regions (2019-2024)
4.2 Americas Hospital-acquired infections (HAIs) Control Market Size Growth (2019-2024)
4.3 APAC Hospital-acquired infections (HAIs) Control Market Size Growth (2019-2024)
4.4 Europe Hospital-acquired infections (HAIs) Control Market Size Growth (2019-2024)
4.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024)
5.2 Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024)
5.3 Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024)
6.2 APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024)
6.3 APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hospital-acquired infections (HAIs) Control by Country (2019-2024)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hospital-acquired infections (HAIs) Control by Region (2019-2024)
8.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024)
8.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET FORECAST

10.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2025-2030)
  10.1.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2025-2030)
  10.1.2 Americas Hospital-acquired infections (HAIs) Control Forecast
  10.1.3 APAC Hospital-acquired infections (HAIs) Control Forecast
  10.1.4 Europe Hospital-acquired infections (HAIs) Control Forecast
  10.1.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast
10.2 Americas Hospital-acquired infections (HAIs) Control Forecast by Country (2025-2030)
  10.2.1 United States Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.2 Canada Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.3 Mexico Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.4 Brazil Hospital-acquired infections (HAIs) Control Market Forecast
10.3 APAC Hospital-acquired infections (HAIs) Control Forecast by Region (2025-2030)
  10.3.1 China Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.2 Japan Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.3 Korea Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.4 Southeast Asia Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.5 India Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.6 Australia Hospital-acquired infections (HAIs) Control Market Forecast
10.4 Europe Hospital-acquired infections (HAIs) Control Forecast by Country (2025-2030)
  10.4.1 Germany Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.2 France Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.3 UK Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.4 Italy Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.5 Russia Hospital-acquired infections (HAIs) Control Market Forecast
10.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast by Region (2025-2030)
  10.5.1 Egypt Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.2 South Africa Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.3 Israel Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.4 Turkey Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.5 GCC Countries Hospital-acquired infections (HAIs) Control Market Forecast
10.6 Global Hospital-acquired infections (HAIs) Control Forecast by Type (2025-2030)
10.7 Global Hospital-acquired infections (HAIs) Control Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 STERIS Corporation
  11.1.1 STERIS Corporation Company Information
  11.1.2 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
  11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 STERIS Corporation Main Business Overview
  11.1.5 STERIS Corporation Latest Developments
11.2 Advanced Sterilization Products Division
  11.2.1 Advanced Sterilization Products Division Company Information
  11.2.2 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
  11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Advanced Sterilization Products Division Main Business Overview
  11.2.5 Advanced Sterilization Products Division Latest Developments
11.3 Hoffmann-La Roche
  11.3.1 Hoffmann-La Roche Company Information
  11.3.2 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
  11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Hoffmann-La Roche Main Business Overview
  11.3.5 Hoffmann-La Roche Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Hospital-acquired infections (HAIs) Control Product Offered
  11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Becton Dickinson
  11.5.1 Becton Dickinson Company Information
  11.5.2 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
  11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Becton Dickinson Main Business Overview
  11.5.5 Becton Dickinson Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Hospital-acquired infections (HAIs) Control Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Diagnostic techniques
Table 3. Major Players of Dleaning and sterilization
Table 4. Major Players of Treatment
Table 5. Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Table 8. Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Table 11. Global Hospital-acquired infections (HAIs) Control Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player (2019-2024)
Table 13. Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
Table 14. Hospital-acquired infections (HAIs) Control Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-acquired infections (HAIs) Control Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2019-2024)
Table 19. Global Hospital-acquired infections (HAIs) Control Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2019-2024)
Table 23. Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Table 25. Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Table 27. APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2019-2024)
Table 29. APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Table 31. APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Table 33. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2019-2024)
Table 35. Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Table 37. Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Hospital-acquired infections (HAIs) Control
Table 46. Key Market Challenges & Risks of Hospital-acquired infections (HAIs) Control
Table 47. Key Industry Trends of Hospital-acquired infections (HAIs) Control
Table 48. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. STERIS Corporation Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 53. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
Table 54. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. STERIS Corporation Main Business
Table 56. STERIS Corporation Latest Developments
Table 57. Advanced Sterilization Products Division Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 58. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
Table 59. Advanced Sterilization Products Division Main Business
Table 60. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Advanced Sterilization Products Division Latest Developments
Table 62. Hoffmann-La Roche Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 63. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
Table 64. Hoffmann-La Roche Main Business
Table 65. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Hoffmann-La Roche Latest Developments
Table 67. Pfizer Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 68. Pfizer Hospital-acquired infections (HAIs) Control Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Latest Developments
Table 72. Becton Dickinson Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 73. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
Table 74. Becton Dickinson Main Business
Table 75. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Becton Dickinson Latest Developments

LIST OF FIGURES

Figure 1. Hospital-acquired infections (HAIs) Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hospital-acquired infections (HAIs) Control Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hospital-acquired infections (HAIs) Control Sales Market Share by Country/Region (2023)
Figure 8. Hospital-acquired infections (HAIs) Control Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2023
Figure 10. Hospital-acquired infections (HAIs) Control in General Hospital
Figure 11. Global Hospital-acquired infections (HAIs) Control Market: General Hospital (2019-2024) & ($ Millions)
Figure 12. Hospital-acquired infections (HAIs) Control in Infectious Disease Hospital
Figure 13. Global Hospital-acquired infections (HAIs) Control Market: Infectious Disease Hospital (2019-2024) & ($ Millions)
Figure 14. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2023
Figure 15. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player in 2023
Figure 16. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Hospital-acquired infections (HAIs) Control Market Size 2019-2024 ($ Millions)
Figure 18. APAC Hospital-acquired infections (HAIs) Control Market Size 2019-2024 ($ Millions)
Figure 19. Europe Hospital-acquired infections (HAIs) Control Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2019-2024 ($ Millions)
Figure 21. Americas Hospital-acquired infections (HAIs) Control Value Market Share by Country in 2023
Figure 22. United States Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2023
Figure 27. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2023
Figure 28. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2023
Figure 29. China Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2023
Figure 36. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Figure 37. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Figure 38. Germany Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Hospital-acquired infections (HAIs) Control Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 52. APAC Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 53. Europe Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 55. United States Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 56. Canada Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 59. China Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 60. Japan Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 61. Korea Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 63. India Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 64. Australia Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 65. Germany Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 66. France Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 67. UK Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 68. Italy Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 69. Russia Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 70. Spain Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 73. Israel Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Hospital-acquired infections (HAIs) Control Market Size 2025-2030 ($ Millions)
Figure 76. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Application (2025-2030)